These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

253 related items for PubMed ID: 9040495

  • 1. Neuroprotective effect of NMDA receptor glycine recognition site antagonism persists when brain temperature is controlled.
    Takaoka S, Bart RD, Pearlstein R, Brinkhous A, Warner DS.
    J Cereb Blood Flow Metab; 1997 Feb; 17(2):161-7. PubMed ID: 9040495
    [Abstract] [Full Text] [Related]

  • 2. [Effects of Ginkgo biloba extract against excitotoxicity induced by NMDA receptors and mechanism thereof].
    Xiao ZY, Sun CK, Xiao XW, Lin YZ, Li S, Ma H, Song GR, Cheng R.
    Zhonghua Yi Xue Za Zhi; 2006 Sep 19; 86(35):2479-84. PubMed ID: 17156678
    [Abstract] [Full Text] [Related]

  • 3. In vivo models of cerebral ischemia: effects of parenterally administered NMDA receptor glycine site antagonists.
    Warner DS, Martin H, Ludwig P, McAllister A, Keana JF, Weber E.
    J Cereb Blood Flow Metab; 1995 Mar 19; 15(2):188-96. PubMed ID: 7860652
    [Abstract] [Full Text] [Related]

  • 4. Neuroprotection (focal ischemia) and neurotoxicity (electroencephalographic) studies in rats with AHN649, a 3-amino analog of dextromethorphan and low-affinity N-methyl-D-aspartate antagonist.
    Tortella FC, Britton P, Williams A, Lu XC, Newman AH.
    J Pharmacol Exp Ther; 1999 Oct 19; 291(1):399-408. PubMed ID: 10490930
    [Abstract] [Full Text] [Related]

  • 5. The pre-ischaemic neuroprotective effect of a novel polyamine antagonist, N1-dansyl-spermine in a permanent focal cerebral ischaemia model in mice.
    Li J, Henman MC, Doyle KM, Strbian D, Kirby BP, Tatlisumak T, Shaw GG.
    Brain Res; 2004 Dec 10; 1029(1):84-92. PubMed ID: 15533319
    [Abstract] [Full Text] [Related]

  • 6. In vivo neuroprotective effects of ACEA 1021 confirmed by magnetic resonance imaging in ischemic stroke.
    Petty MA, Neumann-Haefelin C, Kalisch J, Sarhan S, Wettstein JG, Juretschke HP.
    Eur J Pharmacol; 2003 Aug 01; 474(1):53-62. PubMed ID: 12909195
    [Abstract] [Full Text] [Related]

  • 7. The glycine antagonist GV150526 protects somatosensory evoked potentials and reduces the infarct area in the MCAo model of focal ischemia in the rat.
    Bordi F, Pietra C, Ziviani L, Reggiani A.
    Exp Neurol; 1997 Jun 01; 145(2 Pt 1):425-33. PubMed ID: 9217078
    [Abstract] [Full Text] [Related]

  • 8. L-687,414, a low efficacy NMDA receptor glycine site partial agonist in vitro, does not prevent hippocampal LTP in vivo at plasma levels known to be neuroprotective.
    Priestley T, Marshall GR, Hill RG, Kemp JA.
    Br J Pharmacol; 1998 Aug 01; 124(8):1767-73. PubMed ID: 9756395
    [Abstract] [Full Text] [Related]

  • 9. -(S)-Alpha-phenyl-2-pyridine-ethanamine Dihydrochloride-, a low affinity uncompetitive N-methyl-D-aspartic acid antagonist, is effective in rodent models of global and focal ischemia.
    Cregan EF, Peeling J, Corbett D, Buchan AM, Saunders J, Auer RN, Gao M, Mccarthy DJ, Eisman MS, Campbell TM, Murray RJ, Stagnitto ML, Palmer GC.
    J Pharmacol Exp Ther; 1997 Dec 01; 283(3):1412-24. PubMed ID: 9400017
    [Abstract] [Full Text] [Related]

  • 10. Neuroprotection by 2-h postischemia administration of two free radical scavengers, alpha-phenyl-n-tert-butyl-nitrone (PBN) and N-tert-butyl-(2-sulfophenyl)-nitrone (S-PBN), in rats subjected to focal embolic cerebral ischemia.
    Yang Y, Li Q, Shuaib A.
    Exp Neurol; 2000 May 01; 163(1):39-45. PubMed ID: 10785442
    [Abstract] [Full Text] [Related]

  • 11. Effect of D-(E)-2-amino-4-methyl-5-phosphono-3-pentenoic acid on focal cerebral ischemia in cat.
    Okada M, Ueda H, Kometani M, Nakao K.
    Arzneimittelforschung; 1997 Jun 01; 47(6):703-5. PubMed ID: 9239446
    [Abstract] [Full Text] [Related]

  • 12. A dose-response study of neuroprotection using the AMPA antagonist NBQX in rat focal cerebral ischemia.
    Graham SH, Chen J, Lan JQ, Simon RP.
    J Pharmacol Exp Ther; 1996 Jan 01; 276(1):1-4. PubMed ID: 8558416
    [Abstract] [Full Text] [Related]

  • 13. Substituted analogues of GV150526 as potent glycine binding site antagonists in animal models of cerebral ischemia.
    Di Fabio R, Conti N, De Magistris E, Feriani A, Provera S, Sabbatini FM, Reggiani A, Rovatti L, Barnaby RJ.
    J Med Chem; 1999 Sep 09; 42(18):3486-93. PubMed ID: 10479281
    [Abstract] [Full Text] [Related]

  • 14. Structure-activity relationships of alkyl- and alkoxy-substituted 1,4-dihydroquinoxaline-2,3-diones: potent and systemically active antagonists for the glycine site of the NMDA receptor.
    Cai SX, Kher SM, Zhou ZL, Ilyin V, Espitia SA, Tran M, Hawkinson JE, Woodward RM, Weber E, Keana JF.
    J Med Chem; 1997 Feb 28; 40(5):730-8. PubMed ID: 9057859
    [Abstract] [Full Text] [Related]

  • 15. Reduction of cerebral infarct size by non-competitive AMPA antagonists in rats subjected to permanent and transient focal ischemia.
    Matucz E, Móricz K, Gigler G, Simó A, Barkóczy J, Lévay G, Hársing LG, Szénási G.
    Brain Res; 2004 Sep 03; 1019(1-2):210-6. PubMed ID: 15306255
    [Abstract] [Full Text] [Related]

  • 16. mGluR1 antagonist decreases tyrosine phosphorylation of NMDA receptor and attenuates infarct size after transient focal cerebral ischemia.
    Murotomi K, Takagi N, Takayanagi G, Ono M, Takeo S, Tanonaka K.
    J Neurochem; 2008 Jun 03; 105(5):1625-34. PubMed ID: 18248625
    [Abstract] [Full Text] [Related]

  • 17. Competitive inhibition at the glycine site of the N-methyl-D-aspartate receptor mediates xenon neuroprotection against hypoxia-ischemia.
    Banks P, Franks NP, Dickinson R.
    Anesthesiology; 2010 Mar 03; 112(3):614-22. PubMed ID: 20124979
    [Abstract] [Full Text] [Related]

  • 18. Neuroprotective effects of a postischemic treatment with a bradykinin B2 receptor antagonist in a rat model of temporary focal cerebral ischemia.
    Lumenta DB, Plesnila N, Kläsner B, Baethmann A, Pruneau D, Schmid-Elsaesser R, Zausinger S.
    Brain Res; 2006 Jan 19; 1069(1):227-34. PubMed ID: 16378603
    [Abstract] [Full Text] [Related]

  • 19. The neuroprotective effect of the glycine site antagonist 3R-(+)-cis-4-methyl-HA966 (L-687,414) in a rat model of focal ischaemia.
    Gill R, Hargreaves RJ, Kemp JA.
    J Cereb Blood Flow Metab; 1995 Mar 19; 15(2):197-204. PubMed ID: 7860653
    [Abstract] [Full Text] [Related]

  • 20. Effects of ifenprodil, a polyamine site NMDA receptor antagonist, on reperfusion injury after transient focal cerebral ischemia.
    Doğan A, Rao AM, Başkaya MK, Rao VL, Rastl J, Donaldson D, Dempsey RJ.
    J Neurosurg; 1997 Dec 19; 87(6):921-6. PubMed ID: 9384405
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.